Revenue from Contract with Customer, Excluding Assessed Tax of HeartSciences Inc. from 31 Jul 2021 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
HeartSciences Inc. quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 31 Jul 2021 to 31 Jan 2026.
  • HeartSciences Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 31 Jan 2026 was $0.
  • HeartSciences Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $4,350, a 77% decline from 2023.
  • HeartSciences Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $18,600, a 261% increase from 2022.
  • HeartSciences Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $5,150, a 64% decline from 2021.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Change (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)

HeartSciences Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $0 $0 01 Nov 2025 31 Jan 2026 10-Q 16 Mar 2026 2026 Q3
Q3 2025 $2,419 01 Aug 2025 31 Oct 2025 10-Q 15 Dec 2025 2025 Q2
Q2 2025 $1,900 01 May 2025 31 Jul 2025 10-Q 11 Sep 2025 2025 Q1
Q4 2024 $0 -$14,700 -100% 01 Nov 2024 31 Jan 2025 10-Q 16 Mar 2026 2026 Q3
Q4 2023 $14,700 +$12,750 +654% 01 Nov 2023 31 Jan 2024 10-Q 13 Mar 2025 2025 Q3
Q3 2023 $3,900 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q2
Q4 2022 $1,950 -$790 -29% 01 Nov 2022 31 Jan 2023 10-Q 14 Mar 2024 2024 Q3
Q2 2022 $3,200 -$4,284 -57% 01 May 2022 31 Jul 2022 10-Q 14 Sep 2023 2024 Q1
Q4 2021 $2,740 01 Nov 2021 31 Jan 2022 10-Q 16 Mar 2023 2023 Q3
Q2 2021 $7,484 01 May 2021 31 Jul 2021 10-Q 12 Sep 2022 2023 Q1

HeartSciences Inc. Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $4,350 -$14,250 -77% 01 May 2024 30 Apr 2025 10-K 24 Jul 2025 2025 FY
2023 $18,600 +$13,450 +261% 01 May 2023 30 Apr 2024 10-K 24 Jul 2025 2025 FY
2022 $5,150 -$9,223 -64% 01 May 2022 30 Apr 2023 10-K 29 Jul 2024 2024 FY
2021 $14,373 01 May 2021 30 Apr 2022 10-K 19 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.